Integrated Core Strategies (US) LLC 13D/13G Filings for Tenax Therapeutics, Inc. (TENX)

Integrated Core Strategies (US) LLC 13D and 13G filings for Tenax Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-06-30
4:34 pm
Purchase
2025-06-26 13G Tenax Therapeutics, Inc.
TENX
Integrated Core Strategies (US) LLC 233,616
5.600%
233,616increase
(New Position)
Filing